Article Information
History
- March 29, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Thiagarajan Venkataraman1,†,
- Harish Swaminathan2,†,
- Cesar A. Arze2,†,
- Sarah M. Jacobo2,
- Agamoni Bhattacharyya2,
- Tyler David2,
- Dhananjay M. Nawandar2,
- Simon Delagrave2,
- Vinidhra Mani3,
- Nathan L. Yozwiak2,* and
- H. Benjamin Larman1,*
- 1Institute for Cell Engineering, Division of Immunology, Department of Pathology, Johns Hopkins University, Baltimore, MD, USA
- 2Ring Therapeutics, Cambridge, MA, USA
- 3Flagship Pioneering, Cambridge, MA, USA
- ↵*Corresponding authors: H. Benjamin Larman, Ph.D., Miller Research Building, Room 607, Baltimore, MD 21205. Phone: 410-614-6525. Email: hlarman1{at}jhu.edu. Nathan L. Yozwiak, Ph.D., 620 Memorial Drive, Cambridge, MA 02139. Phone: 617-949-5242. Email: nyozwiak{at}ringtx.com.
↵† These authors contributed equally to this work.